Case number 2016-1621
Supernus Pharmaceuticals, Inc v. Actavis Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 10, 2016 | 5 | ORDER filed. The motion to dismiss [332155-2] is granted. 2016-1621, 2016-1763, and 2016-1764 are dismissed. Each side shall bear its own costs as to those appeals. Appellants' principal brief in 2016-1619 is due no later than May 9, 2016; Appellee's response brief is due no later than July 8, 2016; and Appellants' reply brief is due no later than July 22, 2016. The revised official caption for 2016-1619 is reflected in the order. ISSUED AS A MANDATE (as to 2016-1621, 2016-1763, and 2016-1764 only): May 10, 2016. Service: 05/10/2016 by clerk. [333663] [16-1619, 16-1621, 16-1763, 16-1764] [LMS] [Entered: 05/10/2016 10:20 AM] (3) |
| Mar 4, 2016 | 4 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: APPELLANTS' transcript purchase order form Docket No. [3], ERROR: The filing was made in the consolidated case docket. CORRECTION: All filings should be made only in the lead case docket 16-1619. Please re-file the document in 16-1619. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [315848] [AT] [Entered: 03/04/2016 08:40 AM] (0) |
| Mar 3, 2016 | 3 | Transcript Purchase Order Form for the Appellants Actavis Inc., Actavis Pharma, Inc., Anda, Inc., Watson Laboratories, Inc. and Watson Laboratories, Inc. - Florida indicating that a transcript is already on file. Service: 03/03/2016 by email. [315832] [Liza Walsh] [Entered: 03/03/2016 07:36 PM] (3) |
| Feb 24, 2016 | 1 | Appeal docketed. Received: 02/22/2016. [313508]. [AT] [Entered: 02/24/2016 09:34 AM] (23) |
| Feb 24, 2016 | 2 | Note to file: LEAD APPEAL 2016-1619 is consolidated with appeal 2016-1621. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [313513] [AT] [Entered: 02/24/2016 09:37 AM] (0) |
